Jonathan Beer

Company: Bristol Myers Squibb

Job title: Senior Director Diagnostic Sciences

Seminars:

Liquid Biopsy in Precision Oncology 4:30 pm

Successful implementation of Precision Medicine requires accurate and timely biomarker data to inform patient treatment strategies and although tissue remains the gold standard, liquid biopsy testing has many intrinsic advantages The US FDA has approved 5 Companion Diagnostic with plasma as the sample type for use in identifying patients eligible for 15 unique precision medicine…Read more

day: Day 2 PM